Icosapent ethyl and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Icosapent ethyl and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: icosapent
Brand name: Vascepa
Synonyms: Icosapent, Icosapent Ethyl
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Icosapent ethyl-Moxifloxacin
- Icosapent ethyl-Moxifloxacin (Systemic)
- Icosapent ethyl-Moxifloxacin Hydrochloride
- Icosapent ethyl-Moxifloxacin Injection
- Icosapent ethyl-Moxifloxacin Intravenous
- Icosapent ethyl-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Icosapent Ethyl Capsules
- Moxetumomab pasudotox-tdfk Intravenous-Icy Hot
- Moxetumomab pasudotox-tdfk Intravenous-Icy Hot Arthritis Therapy Topical
- Moxetumomab pasudotox-tdfk Intravenous-Icy Hot Lidocaine Plus Menthol
- Moxetumomab pasudotox-tdfk Intravenous-Icy Hot PM
- Moxetumomab pasudotox-tdfk Intravenous-Icy Hot PM (Capsaicin and Menthol Patch)